US regulator gives nod for Moderna’s expanded use of mRNA vaccine
HQ Team June 13, 2025: The US drug regulator approved Moderna Inc.’s respiratory syncytial virus vaccine for expanded use among people aged between.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team June 13, 2025: The US drug regulator approved Moderna Inc.’s respiratory syncytial virus vaccine for expanded use among people aged between.
HQ Team March 7, 2024: An 82-year-old German male, who took Covid-19 vaccine 217 times, did not have his immune system weakened but.
HQ Team March 2, 2024: The US Centers for Disease Control and Prevention Control has revised its Covid-19 isolation recommendations by suggesting patients.
HQ Team October 4, 2023: The US Food and Drug Administration has cleared Novavax’s updated Covid-19 vaccine for emergency use in adolescents 12.
HQ Team October 2, 2023: Hungarian-born biochemist Katalin Kariko and US immunologist Drew Weissman jointly won the Nobel Prize in Physiology or Medicine.
HQ Team August 5, 2023: A new mutant of the COVID-19 virus is spreading across the UK rapidly, and the number of people.
Pfizer set to increase Covid-19 vaccine prices by almost four times in the US